M&T Bank
RYTM icon

M&T Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

M&T Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
+2,178
New +$197K ﹤0.01% 1565
2026
Q1 		– Sell
-2,101
Closed -$225K – 1793
2025
Q4 		$225K Buy
+2,101
New +$223K ﹤0.01% 1516

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

M&T Bank's RYTM Position: Q2 2026 in Review

M&T Bank opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 2,178 shares worth $242K. The stake represents ﹤0.01% of the portfolio and ranks #1565 among its holdings. This is a return to the name: M&T Bank previously reported a position in RYTM as recently as Q4 2025.

M&T Bank first reported a position in RYTM in Q4 2025 and has held it in 2 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • M&T Bank held 2,178 shares of Rhythm Pharmaceuticals worth $242K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new M&T Bank position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1565 holding.
  • M&T Bank first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.